US Pharma MarketingThe post Guardant ordered to pay $245m in DNA sequencing patent dispute appeared first on Medical Device Network.
Guardant ordered to pay $245m in DNA sequencing patent dispute
Guardant plans to appeal the ruling, taking particular issue with a 6% ongoing royalties stipulate outlined in the court’s motion. The post Guardant ordered to pay $245m in DNA sequencing patent dispute appeared first on Medical Device Network .
Guardant plans to appeal the ruling, taking particular issue with a 6% ongoing royalties stipulate outlined in the court’s motion.
Source: Medical Device Network